Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20471520 | 0.96 | LMNA (0.48) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| SCHEMBL10875389 | 0.84 | LMNA (0.68) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| SCHEMBL9600938 | 0.82 | LMNA (0.42) | LMNASMN1; SMN2 | |
| SCHEMBL16981764 | 0.80 | LMNA (0.39) | LMNASMN1; SMN2L3MBTL1ALDH1A1CA1 | |
| SCHEMBL16342153 | 0.75 | LMNA (0.49) | LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2 | |
| SCHEMBL22680970 | 0.74 | LMNA (0.68) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| Diatrizoic Acid SCHEMBL7615048 | 0.72 | LMNA (0.67) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| Diatrizoic Acid SCHEMBL8508 | 0.72 | LMNA (0.67) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| SCHEMBL8374104 | 0.72 | LMNA (0.55) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 | |
| SCHEMBL9298885 | 0.72 | LMNA (0.66) | LMNASMN1; SMN2MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0153992-B1 | WATER SOLUBLE DERIVATIVES OF 3,5-DIACETO AMIDO-2,4,6-TRIIODOBENZOIC ACID AND PROCESS FOR THEIR PREPARATION AND USE | Dr. Franz Köhler Chemie GmbH (DE) | 1991-10-16 | — | — | EP | claimed |
| US-20180162869-A1 | DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF | NANOPHAGIX | 2018-06-14 | — | — | US | disclosed |
| WO-2008101486-A2 | COATED EXPANDABLE SYSTEM | EUROCOR GMBH (DE) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008092435-A2 | BIODEGRADABLE VASCULAR SUPPORT | HEMOTEQ AG (DE) | 2008-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180162869-A1 | DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF | MTOR, RICTOR, RPTOR | LMNA 4113/4885SMN1; SMN2 2369/4885MEN1 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.